Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Indian J Cancer ; 2014 Feb; 51(6_Suppl): s18-20
Article in English | IMSEAR | ID: sea-156779

ABSTRACT

BACKGROUND: We review our experiences with video‑assisted thoracoscopic surgery (VATS) sleeve lobectomy with bronchoplasty for nonsmall‑cell lung cancer, using only two incisions. The aim of this study was to evaluate the technical feasibility and safety of surgical approach. MATERIALS AND METHODS: From January 2013 to January 2014, we completed 15 cases of VATS sleeve lobectomy with bronchoplasty in our hospital. The patients underwent sleeve lobectomy with bronchoplasty at the following locations: right upper lobe (n = 4), right lower and middle lobes (n = 1), left lower lobe (n = 5), and left upper lobe (n = 6). The operation consisted of VATS anatomic sleeve lobectomy with bronchoplasty combined with systematic lymph node dissection, using only two incisions. RESULTS: The patients underwent sleeve lobectomy with bronchoplasty were no postoperative complications. Median operative time was 183 min; median bronchial anastomosis time was 39 min; median blood loss was 170 ml. Pathological examination showed 12 squamous cell carcinomas and 3 adenocarcinoma. Median postoperative chest tube drainage duration was 4.5 days, and median hospital stay was 6.9 days. CONCLUSIONS: Video‑assisted thoracoscopic surgery sleeve lobectomy with bronchoplasty is a feasible and safe surgical approach, using only two incisions. This way of operation can promote the development of surgical technology.


Subject(s)
Adenocarcinoma/therapy , Humans , Lung Neoplasms/therapy , Neoplasms, Squamous Cell/therapy , Pneumonectomy/methods , Thoracoscopy/methods
2.
Femina ; 38(6): 307-310, jun. 2010. tab
Article in Portuguese | LILACS | ID: lil-600190

ABSTRACT

Este trabalho teve como objetivo identificar a melhor conduta para mulheres adolescentes com diagnóstico citopatológico de atipias de significado indeterminado em células escamosas (ASC-US) e de lesão intraepitelial de baixo grau (LSIL). Foi realizada pesquisa na literatura médica procurando se identificar, criticar e extrair informações de fontes nacionais e internacionais, incluindo as recomendações publicadas em diretrizes relacionadas ao tema. Essa revisão teve como bases de dados: MEDLINE (por meio do PubMed), LILACS, EBSCO e Google Acadêmico. As diretrizes e as recomendações foram identificadas e aquelas relacionadas ao tema foram avaliadas segundo sua validade, sendo, então, sumarizadas. As recomendações feitas por Moscicki, pelo American College of Obstetricians and Gynecologists e pelo consenso australiano indicam encaminhamento à colposcopia após alteração citopatológica em duas amostras com intervalo de 12 meses, enquanto a recomendação do Ministério da Saúde do Brasil é o encaminhamento à colposcopia após alteração citopatológica em duas amostras com intervalo de seis meses. Concluiu-se que adolescentes devem ter abordagem cautelosa pela alta possibilidade de regressão da lesão. Foi observado que a conduta mais adotada é a repetição de duas citologias com intervalo de 12 meses, antes do encaminhamento à colposcopia.


The objective of this paper was to identify the best procedure in cases of adolescents which have the diagnosis of atypical squamous cells of undetermined significance (ASC-US) and low-grade squamous intraepithelial lesion (LSIL). A research in medical literature carried out in order to identify, criticize and get information from national and international sources, including the recommendations and guidelines on this subject. The databases used in this review were MEDLINE (by PubMed), LILACS, EBSCO and Google Scholar. The guidelines and recommendations were summarized according to their validity. The recommendations made by Moscicki, by the American College of Obstetricians and Gynecologists and the Australian consensus indicate colposcopy only after two abnormals cytopathological exams with interval of 12 months. The Brazilian Health Ministry recommends colposcopy after two abnormal cytopathological exams with interval of six months. It was concluded that the approach on the adolescent women should be cautious because of the high possibility of regression of the wound. It was observed that the best procedure is the repetition of 2 exams, in an interval of 12 months, before referring the patient to colposcopy.


Subject(s)
Humans , Female , Adolescent , Uterine Cervical Dysplasia , Clinical Laboratory Techniques , Colposcopy , Early Detection of Cancer/methods , Papillomavirus Infections/diagnosis , Neoplasm Regression, Spontaneous , Mass Screening/methods , Young Adult , Neoplasms, Squamous Cell/therapy
3.
Rev. salud pública ; 12(1): 1-13, feb. 2010. ilus, tab
Article in Spanish | LILACS | ID: lil-552316

ABSTRACT

Objetivo Evaluar el acceso y la oportunidad al diagnóstico y al tratamiento que tienen las pacientes con lesiones cervicales de alto grado o cáncer de acuerdo con el reporte citológico, en Colombia entre junio 2005 a junio del 2006. Metodología Estudio retrospectivo mediante encuestas a una muestra de mujeres con anormalidad citológica residentes de cuatro departamentos de Colombia seleccionados por conveniencia en relación con diferentes tasas de mortalidad. Se realizó análisis descriptivo y se compararon las diferencias entre los departamentos. Resultados El 27 por ciento de las mujeres con lesiones de alto grado o invasoras no tuvieron acceso a alguno de los servicios diagnósticos o terapéuticos por razones de tipo administrativo de los servicios de salud, razones clínicas y culturales de las mujeres. Discusión Un elemento crítico que explica el bajo impacto en la mortalidad por cáncer de cuello uterino en la mayoría de los países de Latino América es la disociación entre actividades de tamización y las de tratamiento.


Objective Evaluating the opportunity and access to diagnosis and treatment for females having had an abnormal Pap smear (high-grade epithelial lesion and cervical cancer) in Colombia from June 2005 to June 2006. Materials and Methods This was a retrospective appraisal using a semi-closed survey of females having had an abnormal Pap smear with high squamous intraepithelial lesions or cervical cancer living in four Colombian departments. These areas were conveniently selected according to their different mortality rates. A descriptive analysis was made and the departments differences compared. Results It was found that 27 percent of females having high-grade squamous intraepithelial lesion or cervical cancer had no access to any of the diagnostic or therapeutic services. Health service administration problems and clinical and cultural ones affecting the females in the study could explain such results. Discussion Follow-up care after abnormal cytology was very poor and could explain the lack of cervical cancer screening impact in Colombia and in most Latin-American countries.


Subject(s)
Adult , Aged , Female , Humans , Middle Aged , Adenocarcinoma/epidemiology , Biopsy , Uterine Cervical Dysplasia/epidemiology , Cervix Uteri/pathology , Colposcopy , Health Services Accessibility/statistics & numerical data , Mass Screening , Neoplasms, Squamous Cell/epidemiology , Uterine Cervical Diseases/epidemiology , Uterine Cervical Neoplasms/epidemiology , Vaginal Smears , Adenocarcinoma/diagnosis , Adenocarcinoma/pathology , Adenocarcinoma/prevention & control , Adenocarcinoma/therapy , Uterine Cervical Dysplasia/diagnosis , Uterine Cervical Dysplasia/pathology , Uterine Cervical Dysplasia/prevention & control , Uterine Cervical Dysplasia/therapy , Colombia/epidemiology , Culture , Early Diagnosis , Health Knowledge, Attitudes, Practice , Health Services Accessibility/economics , Health Surveys , Insurance Coverage/statistics & numerical data , Neoplasms, Squamous Cell/diagnosis , Neoplasms, Squamous Cell/pathology , Neoplasms, Squamous Cell/prevention & control , Neoplasms, Squamous Cell/therapy , Patient Acceptance of Health Care/statistics & numerical data , Precancerous Conditions/diagnosis , Precancerous Conditions/epidemiology , Precancerous Conditions/pathology , Precancerous Conditions/therapy , Retrospective Studies , Sampling Studies , Uterine Cervical Diseases/diagnosis , Uterine Cervical Diseases/pathology , Uterine Cervical Diseases/therapy , Uterine Cervical Neoplasms/diagnosis , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/prevention & control , Uterine Cervical Neoplasms/therapy , Vaginal Smears/statistics & numerical data
4.
Bogotá; Instituto Nacional de Cancerología; dic. 2007. 32 p. tab, graf.
Monography in Spanish | LILACS | ID: lil-668559

ABSTRACT

Contexto: El número de pacientes que presentan en su citología un reporte de células escamosas atípicas de significado indeterminado (ASCUS) es cada vez mayor en nuestro medio. Además, la gran heterogeneidad en la orientación y en el manejo que los profesionales de la salud han venido realizando con estas pacientes es preocupante, pues en muchas oportunidades ocasiona escenarios potencialmente graves, de gran repercusión humana, asistencial y económica para las pacientes, los gestores, los profesionales de la salud y, en general, para el país. Objetivos: Establecer para Colombia la estrategia óptima de manejo en las mujeres mayores y menores de 30 años con citología reportada con ASCUS. Métodos: La elaboración de la presente guía se llevó a cabo mediante la metodología de adopción/adaptación de guías de práctica clínica, proceso que se desarrolló en tres fases: La primera consistió en una búsqueda en la literatura de las guías de práctica clínica pertinentes en el tema, a las cuales se les realizó una evaluación de su calidad metodológica, utilizando el instrumento de la colaboración AGREE. A partir de las guías seleccionadas se redactaron las recomendaciones para ser adaptadas a nuestro país. En la segunda fase se realizó un consenso nacional de expertos, el cual, mediante votación, decidió hacer la adaptación transcontextual de las recomendaciones de las guías de práctica clínica.En la tercera fase se realizó una revisión sistemática de la literatura de los dos últimos años (2005-2007) para actualizar las recomendaciones y completar el proceso de adopción/adaptación de guía de práctica clínica. Resultados: A partir de las guías de práctica clínica de mayor calidad y pertinencia clínica, se definieron seis enunciados determinantes para el manejo de las pacientes con citología reportada como ASCUS en nuestro país. Estos puntos fueron sometidos a consenso con el fin de realizar la adopción/adaptación. Debido a que la última guía de práctica clínica fue publicada en el 2006, se llevó a cabo una revisión sistemática para actualizar las recomendaciones. Esta revisión llevó a una nueva guía de práctica clínica con diferencias en las recomendaciones sobre el manejo de grupos especiales (adolescentes e inmunosuprimidas), por lo cual se analizaron los estudios primarios que las fundamentaban y de allí se procedió a redactar las recomendaciones definitivas. Conclusión: Las estrategias de manejo en las pacientes con citología reportada como ASC-US contemplan las siguientes opciones: seguimiento con citologías con diferentes intervalos, remisión a colposcopia inmediata y realización de la prueba de ADN-VPH.


Subject(s)
Humans , Female , Neoplasms, Squamous Cell/therapy , Practice Guidelines as Topic , Therapeutics/methods , Therapeutics , Colombia
5.
Arq. gastroenterol ; 40(4): 256-261, out.-dez. 2003. ilus, tab
Article in English | LILACS | ID: lil-359889

ABSTRACT

RACIONAL: O desenvolvimento do câncer de esôfago humano é um processo progressivo de diversas etapas. Um indicador precoce deste processo é o aumento na proliferação das células epiteliais esofágicas, incluindo alterações morfológicas, como hiperplasia das células basais, displasia, carcinoma in situ e carcinoma avançado de células escamosas do esôfago. Ao nível celular, o processo de carcinogênese está relacionado com alterações no controle de proliferação celular, diferenciação e morte celular programada (apoptose). A maioria das células tumorais contém alterações genéticas que se relacionam com o controle desses processos, incluindo fatores de transcrição e proteínas relacionadas à apoptose. OBJETIVO: Neste artigo de revisão apresenta-se o conhecimento acerca do perfil genético deste subgrupo de tumor do esôfago, focando-se no potencial desenvolvimento de novas ferramentas para o tratamento clínico do carcinoma avançado de células escamosas do esôfago. CONCLUSÕES: O avanço no campo da biologia molecular tem permitido um maior conhecimento do processo de carcinogênese do esôfago, que deve resultar em benefícios aos pacientes com câncer. Desta forma, espera-se que um melhor entendimento das alterações moleculares durante a carcinogênese aumente o controle e a prevenção ao câncer e também possa levar ao tratamento melhorado da doença.


Subject(s)
Humans , Esophageal Neoplasms/genetics , Neoplasms, Squamous Cell/genetics , Apoptosis , Esophageal Neoplasms/pathology , Esophageal Neoplasms/therapy , Genes, Tumor Suppressor , Neoplasms, Squamous Cell/pathology , Neoplasms, Squamous Cell/therapy , Oncogenes
SELECTION OF CITATIONS
SEARCH DETAIL